Eco R1 Capital, LLC Kymera Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $16.6 Million - $27.3 Million	796,093 New	796,093 $17.3 Million
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $24.8 Million - $34.6 Million	-519,416 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $13 Million - $21.8 Million	419,416 Added 419.42%	519,416 $25.2 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $2.61 Million - $3.33 Million	100,000 New	100,000 $3.23 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.